Galectin Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GALT Nasdaq 2834 http://www.galectintherapeutics.com 1.6589 Stock Down -0.0211

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galectin Therapeutics Inc

Galectin Therapeutics Receives Notice of Chinese Allowance to Grant a Key Patent for Composition of Matter for GR-MD-02 - Sep 12th, 2017 6:30 am
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference - Sep 5th, 2017 6:30 am
Earnings Review and Free Research Report: Zoetis’ Results Beat Estimates in EPS and Revenues; Updated Full Year Guidance - Aug 28th, 2017 5:50 am
Clarification: Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update - Aug 18th, 2017 6:30 am
Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update - Aug 14th, 2017 6:15 am
Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics - Jul 25th, 2017 6:30 am
Galectin Therapeutics to Present at the Singular Research Summer Conference - Jul 7th, 2017 10:00 am
Ammo, Inc. Appoints Two Senior Executives to Board of Directors - Jun 29th, 2017 7:02 am
[$$] Drug Companies Seek to Raise Awareness of Liver Ailment - Jun 23rd, 2017 5:00 am
Can The Uptrend Continue for Galectin Therapeutics (GALT)? - Apr 28th, 2017 5:36 am
Will Henry Schein (HSIC) Deliver a Surprise in Q1 Earnings? - Apr 24th, 2017 6:59 am
Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings? - Apr 24th, 2017 6:53 am
Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store? - Apr 20th, 2017 7:08 am
Can Mead Johnson (MJN) Spring a Surprise in Q1 Earnings? - Apr 20th, 2017 6:49 am